Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EntreMed identifies peptide fragment of tissue factor pathway inhibitor

Jan. 27, 2004

European approval recommended for Lysodren

Jan. 27, 2004

CPMP recommends extension of Paxene indications

Jan. 27, 2004

CR-4: a novel tyrosine kinase inhibitor active against ALL and AML cell lines

Jan. 27, 2004

Onyvax and Mayo Clinic to develop cancer vaccines for ovarian cancer

Jan. 26, 2004

Zevalin radioimmunotherapy receives European approval

Jan. 26, 2004

CytoGenix and Baylor to test aerosol gene silencing agent on mouse lung cancer

Jan. 23, 2004

OSI commences rolling NDA submission for Tarceva for NSCLC

Jan. 23, 2004

PI-88 enters phase II melanoma trial

Jan. 23, 2004

Tubercin shows activity in mouse metastatic melanoma

Jan. 23, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...